Advanced imaging, radiation exposure up over last decade

This article originally appeared here.
Share this content:
Advanced Imaging, Radiation Exposure Up Over Last Decade
Advanced Imaging, Radiation Exposure Up Over Last Decade

(HealthDay News) -- From 1996 to 2010 there was an increase in the use of advanced diagnostic imaging and associated radiation exposure within integrated health care systems, according to a study published in the June 13 issue of the Journal of the American Medical Association.

To estimate trends in imaging utilization and associated radiation exposure, Rebecca Smith-Bindman, M.D., from the University of California in San Francisco, and colleagues retrospectively analyzed electronic medical records for one to two million member-patients of six large integrated health systems across the United States each year.

The researchers found that, over the study period, enrollees underwent a total of 30.9 million imaging examinations (1.18 tests per person per year). Advanced diagnostic imaging, including computed tomography (CT), magnetic resonance imaging (MRI), nuclear medicine, and ultrasound, accounted for 35 percent of the examinations. From 1996 to 2010, the use of advanced diagnostic imaging increased, with annual increases of 7.8, 10, and 3.9 percent, respectively, for CT, MRI, and ultrasound. Use of nuclear medicine decreased 3 percent annually, but there was a 57 percent annual growth rate in positron emission tomography after 2004. Increased use of CT over the study period correlated with an increase in radiation exposure, with a doubling of the mean per capita effective dose and the proportion of patients exposed to high or very-high radiation annually. By 2010, 6.8 and 3.9 percent of those who underwent imaging received high and very-high annual radiation exposure, respectively.

"The increase in use of advanced diagnostic imaging has almost certainly contributed to both improved patient care processes and outcomes, but there are remarkably few data to quantify the benefits of imaging," the authors write.

Full Text

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs